Stay updated with breaking news from Michael Vi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For GM, potential profit from autonomous tech establishes a hedge against slower-than-forecast consumer uptake of battery-electric vehicles. Read more about GM's commercial side.
Boehringer announced that the FDA approved Spevigo for generalized pustular psoriasis flares in adults, the first drug approved for this indication.
Boehringer announced that the FDA approved Spevigo for generalized pustular psoriasis flares in adults, the first drug approved for this indication.
NIO remains an elevated risk investment, but there is substantial reward potential if everything goes right. See why I have a buy rating on NIO stock.
The deal spread in Unity Software's (U) planned purchase of ironSource (IS) narrowed after a disclosure that AppLovin (APP) was the only company that previously held talks with...